We assessed the pharmacokinetics of fentanyl in 19 infants and children undergoing cardiac surgery for correction of tetralogy of Fallot [8], A-V-canal [4] and transposition of the great arteries [7]. Distribution T(1/2), (10.2 ± 2.4 min) and total body clearance (13.3 ± 6.5 ml/kg/min) were similar to adult values. An elimination t(1/2), (102 ± 85 min) shorter than in adults is readily explained by the significantly smaller distribution volume of the drug ( 1,203 ± 777 ml/kg). Good correlation was found between distribution volume (Ass) and elimination t(1/2), (r = 0.86, p < 0.01) and between Vss and age of patients with tetralogy of Fallot (r = 0.85, p < 0.01). However, older children with Fallot’s had higher values of P0(2) due to a milder condition (r = 0.89, p < 0.01); consequently P0(2) correlated positively with Vss (r = 0.76, p = 0.05). Fentanyl total body clearance (TBC) tends to decrease with age in these patients (r = 0.66, p = 0.05) similar to noncardiac children. Our studies suggest that the alterations in the distribution volume of fentanyl in these children may largely depend upon the severity of the hemodynamic disturbance whereas TBC of the drug may depend on their age.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.